Expanded Access Program - Single Patient Emergency Use for Olorofim

Principal Investigator

David De Gijsel

Study Number

STUDY02003061

Available at the following location(s)

  • Lebanon

Do you need help with some of the labels on this page?
Read our glossary of terms